What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Cancer
His primary scientific interests are in Internal medicine, Surgery, Immunology, Gastroenterology and Vasculitis.
Microscopic polyangiitis, Cyclophosphamide, Survival rate, Interstitial lung disease and Pulmonary function testing are among the areas of Internal medicine where Luc Mouthon concentrates his study.
His work focuses on many connections between Microscopic polyangiitis and other disciplines, such as Polyarteritis nodosa, that overlap with his field of interest in Pediatrics.
The various areas that Luc Mouthon examines in his Surgery study include Pulmonary hypertension, Cardiology and Cohort.
In his study, which falls under the umbrella issue of Gastroenterology, Vascular disease is strongly linked to Systemic disease.
He interconnects Glomerulonephritis, Proteinuria, Multicenter trial and Rheumatology in the investigation of issues within Vasculitis.
His most cited work include:
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. (689 citations)
- Early Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis A French Nationwide Prospective Multicenter Study (605 citations)
- Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis (520 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Immunology, Surgery, Gastroenterology and Vasculitis.
Many of his studies involve connections with topics such as Cardiology and Internal medicine.
His Immunology study is mostly concerned with Antibody, Autoantibody, Immune system, Autoimmune disease and Autoimmunity.
His Antibody research includes elements of Antigen and Pathology.
His Surgery study focuses on Retrospective cohort study in particular.
Luc Mouthon studies Anti-neutrophil cytoplasmic antibody which is a part of Vasculitis.
He most often published in these fields:
- Internal medicine (36.93%)
- Immunology (28.27%)
- Surgery (15.19%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (36.93%)
- Vasculitis (14.13%)
- Granulomatosis with polyangiitis (10.07%)
In recent papers he was focusing on the following fields of study:
Luc Mouthon mainly investigates Internal medicine, Vasculitis, Granulomatosis with polyangiitis, Gastroenterology and Cohort.
He performs integrative study on Internal medicine and In patient in his works.
In Vasculitis, Luc Mouthon works on issues like Interquartile range, which are connected to Organ involvement.
He focuses mostly in the field of Granulomatosis with polyangiitis, narrowing it down to topics relating to Eosinophilic and, in certain cases, Churg strauss and Asthma.
His Gastroenterology research includes themes of Giant cell arteritis, Case-control study and Interstitial lung disease.
His Microscopic polyangiitis study incorporates themes from Mononeuritis Multiplex and Anti-neutrophil cytoplasmic antibody.
Between 2018 and 2021, his most popular works were:
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. (689 citations)
- Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data. (237 citations)
- Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19. (164 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
His primary areas of study are Internal medicine, Randomized controlled trial, Gastroenterology, Disease and Interstitial lung disease.
Luc Mouthon integrates Internal medicine and Hydroxychloroquine in his studies.
His Randomized controlled trial study combines topics from a wide range of disciplines, such as Research design, Program evaluation, Rituximab, Mental health and Physical therapy.
The Gastroenterology study combines topics in areas such as Odds ratio, Renal function, Retinopathy, Case-control study and Computed tomography.
His research in Disease focuses on subjects like Intensive care medicine, which are connected to Azathioprine and Juvenile dermatomyositis.
His Interstitial lung disease research is multidisciplinary, relying on both Smoking cessation, Pulmonary hypertension, Chest ct, Connective tissue disease and Combined pulmonary fibrosis and emphysema.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
